CHM Cannabis
Home > Boards > Free Zone > All Trading - Technical > $Most Followed Members$

$PMCB The "Financial Times”, the world’s leading global

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
$Pistol Pete$ Member Profile
Member Level 
Followed By 2,162
Posts 228,586
Boards Moderated 58
Alias Born 05/06/14
160x600 placeholder
Apple Hit With iPhone Sales Ban in China, Qualcomm Says -- 4th Update
A Chinese court ordered Apple Inc. to stop selling older iPhone models after finding the company infringed on two patents held by Qualcomm Inc., the chip maker said, casting uncertainty over Apple's business in a critical market amid thorny trade relations between the U.S. and China.
Engie Won't Change Its Stake in Suez -Les Echos
Shire plc Rule 2.9 Announcement
Top Company News of the Day
Top Company News of the Day
Former Leighton Executive Found Guilty of Criminal Charges
Top Company News of the Day
Top Company News of the Day
U.S.-China Trade Talks Get Under Way
CBS Directors Fear Legal Risks from Leaks in Moonves Probe
$Pistol Pete$ Member Level  Thursday, 03/08/18 01:20:57 AM
Re: $Pistol Pete$ post# 18148
Post # of 19522 
$PMCB The "Financial Times”, the world’s leading global business publication, has just published that PharmaCyte has completed the preparation of the Master Cell Bank of the cells destined to be part of the treatment for pancreatic cancer and the cells will now enter the testing phase. Both of these activities were performed by Eurofins as a subcontractor. Austrianova will receive the cells, once testing is complete, and commence the manufacture of the the encapsulated cell clinical trial product

https://markets.ft.com/data/announce/detail?dockey=600-201802060900BIZWIRE_USPRX____BW5609-1



investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist